Skip to content

Drug interactions

Carmustine + Siponimod

Severity: Major

Carmustine and Siponimod: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carmustine is an alkylating agent that causes delayed and cumulative myelosuppression. With siponimod's lymphocyte-lowering effect, the combination may increase the risk of serious infection.

What this interaction means in plain words

Carmustine and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Carmustine belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression from S1P-mediated lymphocyte sequestration and alkylating agent bone marrow toxicity.

What to do

Avoid concurrent use where possible and consider interrupting siponimod during chemotherapy. If combined, monitor complete blood counts closely, including delayed nadirs, and watch for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carmustine and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Carmustine with Siponimod?

MediHelp rates the interaction as major. Carmustine and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Carmustine is an alkylating agent that causes delayed and cumulative myelosuppression. With siponimod's lymphocyte-lowering effect, the combination may increase the risk of serious infection.

How serious is the interaction between Carmustine and Siponimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and consider interrupting siponimod during chemotherapy. If combined, monitor complete blood counts closely, including delayed nadirs, and watch for infection.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in